Loebel, M.* ; Eckey, M.* ; Sotzny, F.* ; Hahn, E.G.* ; Bauer, S.* ; Grabowski, P.* ; Zerweck, J.* ; Holenya, P.* ; Hanitsch, L.G.* ; Wittke, K.* ; Borchmann, P.* ; Rüffer, J.U.* ; Hiepe, F.* ; Ruprecht, K.* ; Behrends, U. ; Meindl, C. ; Volk, H.D.* ; Reimer, U.* ; Scheibenbogen, C.*
     
    
        
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    
    
        
    
    
        
        PLoS ONE 12:e0179124 (2017)
    
    
    
      
      
	
	    Background: Epstein-Barr-Virus (EBV) plays an important role as trigger or cofactor for various autoimmune diseases. In a subset of patients with Chronic Fatigue Syndrome (CFS) disease starts with infectious mononucleosis as late primary EBV-infection, whereby altered levels of EBVspecific antibodies can be observed in another subset of patients. Methods: We performed a comprehensive mapping of the IgG response against EBV comparing 50 healthy controls with 92 CFS patients using a microarray platform. Patients with multiple sclerosis (MS), systemic lupus erythematosus (SLE) and cancer-related fatigue served as controls. 3054 overlapping peptides were synthesised as 15-mers from 14 different EBV proteins. Array data was validated by ELISA for selected peptides. Prevalence of EBV serotypes was determined by qPCR from throat washing samples. Results: EBV type 1 infections were found in patients and controls. EBV seroarray profiles between healthy controls and CFS were less divergent than that observed for MS or SLE. We found significantly enhanced IgG responses to several EBNA-6 peptides containing a repeat sequence in CFS patients compared to controls. EBNA-6 peptide IgG responses correlated well with EBNA-6 protein responses. The EBNA-6 repeat region showed sequence homologies to various human proteins. Conclusion: Patients with CFS had a quite similar EBV IgG antibody response pattern as healthy controls. Enhanced IgG reactivity against an EBNA-6 repeat sequence and against EBNA-6 protein is found in CFS patients. Homologous sequences of various human proteins with this EBNA-6 repeat sequence might be potential targets for antigenic mimicry.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Epstein-barr-virus; Systemic-lupus-erythematosus; Cells In-vivo; Epithelial-cells; Antibody-responses; Lymphoproliferative Disorders; Nasopharyngeal Carcinoma; Rheumatoid-arthritis; Multiple-sclerosis; Peripheral-blood
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2017
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2017
    
 
    
    
        ISSN (print) / ISBN
        1932-6203
    
 
    
        e-ISSN
        
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 12,  
	    Issue: 6,  
	    Pages: ,  
	    Article Number: e0179124 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Public Library of Science (PLoS)
        
 
        
            Publishing Place
            Lawrence, Kan.
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Immune Response and Infection
    
 
    
        PSP Element(s)
        G-501500-001
    
 
    
        Grants
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
        Erfassungsdatum
        2017-07-26